Taken together, our results suggest that targeting TIM3 effectively promotes M1 macrophage polarization to reduce TGF-β secretion, leading to inactivation of HSCs and inhibition of fibrosis in NASH development. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.